Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
Focusing on small molecule drug discovery and development for cancer and autoimmune diseases
BOSTON, Nov. 24, 2021 -- (Healthcare Sales & Marketing Network) -- Allorion Therapeutics, a company focusing on next-generation precision medicine for oncology... Biopharmaceuticals, Venture Capital Allorion Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Autoimmune Disease | Cancer | Cancer & Oncology | Marketing | Pharmaceuticals | Venture Capital